New York State Common Retirement Fund’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,087
Closed -$794K 3450
2023
Q2
$794K Sell
17,087
-1,828
-10% -$63.2K ﹤0.01% 1887
2023
Q1
$542K Sell
18,915
-3,733
-16% -$111K ﹤0.01% 2141
2022
Q4
$707K Sell
22,648
-2,783
-11% -$90.8K ﹤0.01% 2149
2022
Q3
$516K Buy
25,431
+5,433
+27% +$99K ﹤0.01% 2311
2022
Q2
$310K Buy
19,998
+6,783
+51% +$117K ﹤0.01% 2583
2022
Q1
$253K Buy
13,215
+10,715
+429% +$191K ﹤0.01% 2727
2021
Q4
$63K Buy
+2,500
New +$73.3K ﹤0.01% 3183

New York State Common Retirement Fund's DICE Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 17,087 shares — an estimated $794K sold.

New York State Common Retirement Fund first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $794K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 17,087 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $794K.
  • New York State Common Retirement Fund first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • New York State Common Retirement Fund's DICE Therapeutics, Inc. Common Stock position peaked at $794K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.